Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola K Green

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|January 11, 2003
Adenoviral vectors: systemic delivery and tumor targetingNicola K Green, Leonard W Seymour
Journal of Drug Targeting|August 3, 2007
Passive tumour targeting of polymer-coated adenovirus for cancer gene therapyKerry D Fisher, Nicola K Green, Ashley Hale, et al.
Biotechnology and Bioengineering|March 19, 2019
Adenovirus 5 recovery using nanofiber ion-exchange adsorbentsJordan Turnbull, Bernice Wright, Nicola K Green, et al.
International Journal of Cancer|January 18, 2003
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vectorNicola K Green, Iain A McNeish, Rajeev Doshi, et al.
The Journal of Gene Medicine|April 1, 2003
Vectors based on reducible polycations facilitate intracellular release of nucleic acidsMartin L Read, K Helen Bremner, David Oupický, et al.
Human Gene Therapy|March 5, 2009
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancerJoanne Morrison, Simon S Briggs, Nicola K Green, et al.
Virology|November 12, 2013
Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapyClemens Thoma, Veronique Bachy, Patricia Seaton, et al.
Nanomedicine (London, England)|June 20, 2012
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancerNicola K Green, Ashley Hale, Ryan Cawood, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Blood|January 10, 2009
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Robert C Carlisle, Ying Di, Anna M Cerny, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|January 11, 2003
Adenoviral vectors: systemic delivery and tumor targetingNicola K Green, Leonard W Seymour
Journal of Drug Targeting|August 3, 2007
Passive tumour targeting of polymer-coated adenovirus for cancer gene therapyKerry D Fisher, Nicola K Green, Ashley Hale, et al.
Biotechnology and Bioengineering|March 19, 2019
Adenovirus 5 recovery using nanofiber ion-exchange adsorbentsJordan Turnbull, Bernice Wright, Nicola K Green, et al.
International Journal of Cancer|January 18, 2003
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vectorNicola K Green, Iain A McNeish, Rajeev Doshi, et al.
The Journal of Gene Medicine|April 1, 2003
Vectors based on reducible polycations facilitate intracellular release of nucleic acidsMartin L Read, K Helen Bremner, David Oupický, et al.
Human Gene Therapy|March 5, 2009
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancerJoanne Morrison, Simon S Briggs, Nicola K Green, et al.
Virology|November 12, 2013
Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapyClemens Thoma, Veronique Bachy, Patricia Seaton, et al.
Nanomedicine (London, England)|June 20, 2012
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancerNicola K Green, Ashley Hale, Ryan Cawood, et al.
The Journal of Gene Medicine|January 25, 2008
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancerNicola K Green, Joanne Morrison, Sarah Hale, et al.
Blood|January 10, 2009
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Robert C Carlisle, Ying Di, Anna M Cerny, et al.
Pageof 1